Neurocrine Clinical Site

Nashua, New Hampshire 03060

0 studies enrolling now · 4 studies all time

What they study most

Tardive Dyskinesia, Tourette Syndrome

Studies at this site

• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome — Stopped early
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents — Status unconfirmed